Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amine Dehydrogenase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121022786A reveals a novel AmDH enzyme for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN119040289B enables high-purity chiral amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114686451B reveals mutant amine dehydrogenase for high-purity lactam production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110628739B reveals high-efficiency enzymatic synthesis for chiral amines. Achieve >99% ee and reduced costs with scalable biocatalytic solutions.
Patent CN115975968B reveals novel amine dehydrogenase mutants for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110577941B reveals mutated enzymes for high-purity chiral amine synthesis, offering cost reduction in pharmaceutical intermediate manufacturing via biocatalysis.
Patent CN110577941B details mutated amine dehydrogenase for asymmetric reductive amination, offering high optical purity and scalable biocatalysis for pharmaceutical intermediates.
Patent CN114686451A discloses amine dehydrogenase mutants for high-yield production. Offers cost reduction in pharma intermediate manufacturing with >99% ee.
Patent CN110577941A reveals mutated amine dehydrogenase for asymmetric reductive amination. Enables cost reduction in pharmaceutical intermediates manufacturing with high optical purity.